Biote Corp.
Organization details
- Legal name
- Biote Corp.
- Former names
- Haymaker Acquisition Corp. III
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2833 — Medicinal Chemicals & Botanical Products
- Headquarters city
- Irving
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- BTMD
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001819253
- EIN
- 85-1791125
Board of directors
- Since 2023
-
Bret Christensen · Director · Chief Executive OfficerSince 2025
-
Dana Lynn Jacoby · DirectorSince 2023
-
Debra L. Morris · DirectorSince 2023
-
Marc D. Beer · Director · Executive ChairmanSince 2023
-
Richard R. Barrera · DirectorSince 2025
-
Robert Charles Peterson · Director · Interim CEOSince 2026
-
Stephen Mark Cone · DirectorSince 2023
-
Steven J. Heyer · DirectorSince 2023
-
Teresa Sue Weber · Director · Chief Executive OfficerSince 2023
Chief executives
Solid · grade C
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 35% of the scoring weight is on file.
- Revenue growth 20%
- 30
- Earnings growth 15%
- 100
-2.5% a year in revenue
722.2% a year in earnings per share
35% of the scoring weight is on file. Figures cover December 2024 – December 2025.
Director election results
Annual meeting of May 12, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.2%
-
86.2%
Board connections
3 of this board's directors also sit on 7 other boards. 1 is in the same sector.
- via Andrew R. Heyer and Steven J. Heyer
- via Andrew R. Heyer and Steven J. Heyer
- via Andrew R. Heyer
-
Progyny Inc. Same sectorvia Debra L. Morris
- via Debra L. Morris
- via Andrew R. Heyer
- via Andrew R. Heyer
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $202,204
- 2 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 11, 2026 | Marc D. Beer Director, Officer (Executive Chairman) | Open-market purchase | +16,000 | $1.55 | $24,800 |
| Aug 10, 2026 | Marc D. Beer Director, Officer (Executive Chairman) | Open-market purchase | +115,950 | $1.53 | $177,404 |
| May 12, 2026 | Debra L. Morris Director | Option exercise | +21,407 | — | — |
| May 13, 2025 | Debra L. Morris Director | Option exercise | +11,045 | — | — |
| May 13, 2025 | Dana Lynn Jacoby Director | Option exercise | +12,994 | — | — |
| May 7, 2025 | Richard R. Barrera 10% owner | Open-market purchase | +11,677 | $3.35 | $39,118 |
| May 6, 2025 | Richard R. Barrera 10% owner | Open-market purchase | +436,037 | $3.26 | $1,421,481 |
| Apr 30, 2025 | RB Management GP LLC 10% owner | Open-market purchase | +1,933 | $3.30 | $6,379 |
| Apr 21, 2025 | Richard R. Barrera 10% owner | Open-market purchase | +8,801 | $3.27 | $28,779 |
| Apr 17, 2025 | Guines LLC 10% owner | Open-market purchase | +6,874 | $3.29 | $22,615 |
| Apr 16, 2025 | Guines LLC 10% owner | Open-market purchase | +1,000 | $3.29 | $3,290 |
| Apr 9, 2025 | Guines LLC 10% owner | Open-market purchase | +13,532 | $3.21 | $43,438 |
| Apr 8, 2025 | Guines LLC 10% owner | Open-market purchase | +34,907 | $3.21 | $112,051 |
| Apr 7, 2025 | RB Management GP LLC 10% owner | Open-market purchase | +43,378 | $3.15 | $136,641 |
| Apr 4, 2025 | RB Management GP LLC 10% owner | Open-market purchase | +23,741 | $3.24 | $76,921 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Biote Corp.
Who is the CEO of Biote Corp.?
Bret Christensen has been Biote Corp.'s Chief Executive Officer since February 2025.
How many directors are on Biote Corp.'s board?
Biote Corp.'s board has 10 directors: Andrew R. Heyer, Bret Christensen, Dana Lynn Jacoby, Debra L. Morris, Marc D. Beer, Richard R. Barrera, Robert Charles Peterson, Stephen Mark Cone, Steven J. Heyer and Teresa Sue Weber.
Are Biote Corp. insiders buying or selling shares?
Over the last 12 months, Biote Corp. insiders bought $202,204 of shares in 2 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="biote-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.